According to @ai_darpa, Neuralink is advancing its AI-powered brain-computer interface technology with its latest project, Blindsight, aiming to restore vision even for individuals born blind or lacking eyes or optic nerves. The company has already achieved low-resolution vision restoration in monkeys, with human clinical trials awaiting FDA approval. This development highlights a major leap in AI-enabled medical devices and brain tech, opening significant business opportunities in the assistive technology market and demonstrating the practical impact of Neuralink's AI innovations on neural prosthetics for sensory restoration (source: @ai_darpa, Dec 20, 2025).